Eli Lilly And Co (NYSE:LLY) is one of several companies benefitting from demand for weight loss drugs. The company is also seeing competition in the market including knockoff drugs that it said could be unsafe. What Happened: A recent report says Eli Lilly is seeking medical records of people who took knockoff weight loss drugs. The request, reported by Bloomberg, is being done for safety reasons according to the pharmaceutical company. Eli Lilly is building a case against businesses that are selling knockoffs of the company’s Zepbound and Monjaro. Compounding pharmacies have been capitalizing…
